Last quarter (Q ), Biophytis's total revenue was €―, a decrease of ― from the same quarter last year. In Q, Biophytis's net income was €―. See Biophytis’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	-	€ 0.00	€ 0.00	€ 0.00	€ 0.00	€ 0.00
Cost of Revenue	-	-	€ 0.00	€ 0.00	€ 0.00	€ 0.00
Gross Profit	-	-	€ 0.00	€ 0.00	€ 0.00	€ 0.00
Operating Expense	-	€ 26.82M	€ 13.94M	€ 15.68M	€ 13.86M	€ 9.91M
Operating Income	-	€ -26.82M	€ -13.94M	€ -15.68M	€ -13.86M	€ -9.91M
Net Non Operating Interest Income Expense	-	€ -2.53M	€ -1.50M	€ -1.49M	€ -217.00K	€ -3.26M
Other Income Expense	-	€ -1.82M	€ -10.07M	€ -1.85M	-	-
Pretax Income	-	€ -31.16M	€ -25.52M	€ -19.03M	€ -14.06M	€ -11.41M
Tax Provision	-	€ 0.00	€ 0.00	€ -80.00K	€ -72.00K	€ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	€ -31.16M	€ -25.52M	€ -18.95M	€ -13.99M	€ -11.41M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	-	€ 26.82M	€ 13.94M	€ 15.68M	€ 13.86M	€ 9.91M
Net Income From Continuing And Discontinued Operation	-	€ -31.16M	€ -25.52M	€ -18.95M	€ -13.99M	€ -11.41M
Normalized Income	-	€ -29.34M	€ -15.44M	€ -17.10M	€ -13.99M	€ -13.16M
Interest Expense	-	€ 545.00K	€ 817.00K	€ 1.13M	€ 189.00K	€ 3.15M
EBIT	-	€ -30.62M	€ -24.70M	€ -17.90M	€ -13.87M	€ -8.26M
EBITDA	-	€ -30.31M	€ -24.42M	€ -17.64M	€ -13.64M	€ -8.06M

Currency in EUR

Biophytis Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing